Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Fisher Scientific Sponsors Industry Symposia on Stem Cell Research

Published: Tuesday, June 10, 2008
Last Updated: Tuesday, June 10, 2008
Bookmark and Share
Symposium program will unveil new methods and technologies for stem cell scientists.

Thermo Fisher Scientific Inc. has announced its sponsorship of the Industry Wednesday Symposia in Philadelphia on June 11, preceding the 6th International Society for Stem Cell Research (ISSCR) Annual Meeting.

With presentations from leading experts, the Thermo Fisher Scientific symposium, “Strategies and Current Technologies for Accelerating Stem Cell Research”, will provide stem cell scientists with information on the latest tools and techniques available for their research.

The symposium showcases the expertise of Thermo Fisher Scientific around key stem cell research technologies as presented through the company’s Stem Cell Excellence™ program, which was introduced in 2007.

Speakers from industrial and clinical backgrounds will cover topics ranging from the practical considerations for the differentiation of mesenchymal stem cells into hepatocyte-like cells, and the current and future use of pluripotent stem cells.

Thermo Fisher Scientific says that, the delegates will learn about new methods for the quantitative detection of up-regulated and down-regulated proteins and explore techniques used for the discovery and characterization of regulatory molecules involved with differentiation.

Dr. Yair Argon from the department of pathology, Children’s Hospital of Philadelphia, will present data and discuss how the identified GRP94-dependent proteins are essential for embryonic development and the differentiation of embryonic stem cells.

Further topics include: the differentiation of adipose derived and Wharton’s jelly derived mesenchymal stem cells into hepatocyte-like cells, presented by Anant Kamath, COO of Cellular Engineering Technologies; and the current and future uses of pluripotent stem cells, delivered by Robin Wesselschmidt, President of Primogenix.

Thermo Fisher Scientific will also be providing in-depth presentations on the use of RNAi screening for the identification of critical miRNAs for human mesenchymal stem cell differentiation, and the use of high content analysis to accelerate stem cell research.

Julie Sperry, vice president, strategic marketing, Thermo Fisher Scientific said, “We are dedicated to serving the scientific community and feel our wealth of in-house expertise and breadth of best-in-class products can support stem cell scientists with their pioneering research.” Sperry continued, “As such we are delighted to be aligned with this society event. With an excellent program of presentations, we aim to provide information on the technologies and strategies that are currently being applied.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Scientific Signs Agreement with Novartis, Pfizer
Universal test designed for non-small cell lung cancer supports multiple drug development programs.
Thursday, November 26, 2015
Thermo's NGS Platform Selected for Nationwide Clinical Research Program
National Cancer Institute-MATCH trial to sequence thousands of tumor samples using Ion Torrent targeted sequencing technology.
Monday, June 01, 2015
Thermo Fisher Q3 Revenues up 31 Percent
Thermo Fisher announced that revenues grew 31% to $4.17 billion for the third quarter ended September 27, 2014.
Thursday, October 23, 2014
Thermo Reports 22% Revenue Rise in Q1 2014
Results include the addition of Life Technologies as of February 4, 2014, and exclude the previously announced related divestitures as of March 22, 2014.
Wednesday, April 23, 2014
Thermo Completes Life Tech Acquisition
The completion of the transaction follows the receipt of all required regulatory approvals.
Tuesday, February 04, 2014
Thermo Receives EC Clearance for Life Tech Acquisition
Thermo Fisher Scientific announced that it has received approval from the European Commission (EC) for its pending acquisition of Life Technologies Corporation.
Tuesday, November 26, 2013
Thermo Fisher Scientific Opens Its First Dry Powder Media Facility in APAC Region
Singapore facility delivers manufacturing redundancy and increases supply assurance for global biologic drug discovery and production.
Tuesday, August 06, 2013
Thermo Fisher Scientific Announces Application Deadlines for Life Sciences Scholarships
Thermo Scientific Pierce Scholarship Winter/Spring semester applications due December 14, 2012.
Wednesday, November 14, 2012
Thermo Fisher Scientific Expands Scientific Advisory Board
Dr. Klaus Lindpaintner to lead strategic development of innovative analytical technologies.
Thursday, November 08, 2012
Thermo Fisher Scientific Names Recipients of RNAi Discovery Grants
More than $400,000 in RNAi screening tools awarded to advance biomedical research and drug discovery.
Friday, November 06, 2009
Thermo Fisher Scientific Establishes RNAi Discovery Grant Program to Advance Gene Research
Five research projects to receive total of more than $400,000 in RNAi screening tools.
Friday, August 14, 2009
Thermo Fisher Scientific Collaborates with the Institute of Cancer Research to Create Proteomics Laboratory
The ICR's new, proteomics laboratory is equipped with a complete Thermo Scientific proteomics workflow.
Friday, July 24, 2009
Thermo Scientific Offering to be Highlighted at ISSCR Stem Cell Research Symposium
The symposium highlights the latest Thermo Scientific tools and technologies available to researchers to advance their understanding of stem cells.
Tuesday, July 07, 2009
Thermo Fisher Scientific Sponsors Shanghai Conference on Stem Cell Research
Thermo Scientific sponsors the 2009 Shanghai Symposium of Stem Cell Research and Regenerative Medicine at the Shanghai Tong Ji University.
Thursday, May 14, 2009
Thermo Fisher Scientific Welcomes New Members to RNAi Global Initiative
The new member institutions include the Children's Hospital of Eastern Ontario Research Institute and the University of Leiden in Amsterdam.
Monday, March 02, 2009
Scientific News
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Curing Disease by Repairing Faulty Genes
New delivery method boosts efficiency of CRISPR genome-editing system.
'Junk' DNA Plays Role in Preventing Breast Cancer
Supposed "junk" DNA, found in between genes, plays a role in suppressing cancer, according to new research by Universities of Bath and Cambridge.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!